MedPath

Altum Pharmaceuticals Inc

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of AP-002 in Patients With Solid Tumors

Phase 1
Conditions
Solid Tumor
Interventions
First Posted Date
2019-10-29
Last Posted Date
2019-10-31
Lead Sponsor
Altum Pharmaceuticals INC
Target Recruit Count
61
Registration Number
NCT04143789
Locations
🇺🇸

Research Institution, Chicago, Illinois, United States

🇺🇸

Research Site, Saint Louis, Missouri, United States

🇺🇸

Investigational Site, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath